The Bio Report

TFF Pharmaceuticals thin film freezing technology allows it to take vaccines, small molecule drugs, and biologics and turn them into a fine powder. The process not only can be used to eliminate the need for low temperature storage of certain medicines, but also improve the of water solubility of drugs and allow them to be delivered as inhaled therapies. We spoke to Glenn Mattes, president and CEO of TFF Pharmaceuticals, about its platform technology, the company’s efforts to build a pipeline by reformulating existing therapeutics, and its plans to use partnerships to realize the full potential of the technology.